论文部分内容阅读
为了探究对糖尿病合并血栓形成或对其合并血管梗塞性疾病的预防，作者采用活血化瘀的方法，运用中药通瘀灵（自拟方），对２型糖尿病患者进行治疗，着重观察治疗前、后血浆血小板α颗粒膜蛋白ＧＭＰ－１４０和组织纤溶酶激活剂ＴＰＡ及其抑制物ＰＡＩ的活性变化，并探讨其作用?
In order to explore the prevention and treatment of diabetic thrombosis or its associated vascular infarction, the author adopted the method of promoting blood circulation to remove blood stasis and used traditional Chinese medicine Tongyu Ling (self-designed prescription) to treat patients with type 2 diabetes, After plasma platelet α-granule membrane protein GMP-140 and tissue plasminogen activator TPA and its inhibitor PAI activity changes, and to explore its role?